Cargando…
Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis
Multiple sclerosis (MS) is a chronic inflammatory, demyelinating, and neurodegenerative disease of the central nervous system (CNS). In people with MS, impaired remyelination and axonal loss lead to debilitating long-term neurologic deficits. Current MS disease-modifying drugs mainly target peripher...
Autores principales: | Gharagozloo, Marjan, Mace, Jackson W., Calabresi, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669474/ https://www.ncbi.nlm.nih.gov/pubmed/36407761 http://dx.doi.org/10.3389/fnmol.2022.995477 |
Ejemplares similares
-
Remyelination Therapy in Multiple Sclerosis
por: Harlow, Danielle E., et al.
Publicado: (2015) -
Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
por: Packer, Davin, et al.
Publicado: (2023) -
In vivo MRI is sensitive to remyelination in a nonhuman primate model of multiple sclerosis
por: Donadieu, Maxime, et al.
Publicado: (2023) -
Remyelination in multiple sclerosis from the miRNA perspective
por: Maciak, Karina, et al.
Publicado: (2023) -
Remyelination In Multiple Sclerosis
por: Chari, Divya M.
Publicado: (2007)